Observational studyThe Journal of dermatology2025

Real-world safety and effectiveness of guselkumab in patients with psoriasis: A post-marketing surveillance study through up to week 52 in Japan.

Yayoi Tada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.